Gene · 5454
Papers1,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer. | Int J Mol Sci | 2024 | 38673756 | PubTator, text mining | PubMed |
| Lineage Reprogramming: Genetic, Chemical, and Physical Cues for Cell Fate Conversion with a Focus on Neuronal Direct Reprogramming and Pluripotency Reprogramming. | Cells | 2024 | 38667322 | PubTator, text mining | PubMed |
| Identification of potential key ferroptosis- and autophagy-related genes in myelomeningocele through bioinformatics analysis. | Heliyon | 2024 | 38660270 | PubTator, text mining | PubMed |
| ASCL1-mediated direct reprogramming: converting ventral midbrain astrocytes into dopaminergic neurons for Parkinson's disease therapy. | BMB Rep | 2024 | 38649147 | PubTator, text mining | PubMed |
| Transcription Factors in Brain Regeneration: A Potential Novel Therapeutic Target. | Curr Drug Targets | 2024 | 38444255 | PubTator, text mining | PubMed |
| RFX4 is an intrinsic factor for neuronal differentiation through induction of proneural genes POU3F2 and NEUROD1. | Cell Mol Life Sci | 2024 | 38386071 | PubTator, text mining | PubMed |
| Single nuclei transcriptomics in human and non-human primate striatum in opioid use disorder. | Nat Commun | 2024 | 38296993 | PubTator, text mining | PubMed |
| Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells. | Cancers (Basel) | 2024 | 38275910 | PubTator, text mining | PubMed |
| Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research. | Int J Mol Sci | 2024 | 38256166 | PubTator, text mining | PubMed |
| ID2 Promotes Lineage Transition of Prostate Cancer through FGFR and JAK-STAT Signaling. | Cancers (Basel) | 2024 | 38254880 | PubTator, text mining | PubMed |
| DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. | Commun Biol | 2024 | 38238517 | PubTator, text mining | PubMed |
| Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming. | Neural Regen Res | 2024 | 38227517 | PubTator, text mining | PubMed |
| Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma. | iScience | 2024 | 38222111 | PubTator, text mining | PubMed |
| Therapeutic and diagnostic applications of antisense peptide nucleic acids. | Mol Ther Nucleic Acids | 2024 | 38204913 | PubTator, text mining | PubMed |
| Roles and signaling pathways of CITED1 in tumors: overview and novel insights. | J Int Med Res | 2024 | 38190845 | PubTator, text mining | PubMed |
| A promise for neuronal repair: reprogramming astrocytes into neurons in vivo. | Biosci Rep | 2024 | 38175538 | PubTator, text mining | PubMed |
| LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway. | Int J Med Sci | 2024 | 38169586 | PubTator, text mining | PubMed |
| Peptide L13S Derived from the BRN2 POU Domain Reduces Metastasis In Vivo and Inhibits Cell Migration and Invasion In Vitro. | Anticancer Res | 2024 | 38160013 | PubTator, text mining | PubMed |
| LSD1 Regulates Neurogenesis in Human Neural Stem Cells Through the Repression of Human-Enriched Extracellular Matrix and Cell Adhesion Genes. | Stem Cells | 2024 | 38152966 | PubTator, text mining | PubMed |
| BRN1/2 Function in Neocortical Size Determination and Microcephaly. | bioRxiv | 2024 | 37961182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5454/papers?page=4